Hou-Tsung Chen

Hou-Tsung Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in International Journal of Surgery
Verified
Journal Article
Open access
HCHsu Chieh-Cheng
Hsu Chieh-Cheng
KWKay L.H. Wu
Kay L.H. Wu
JPJei-Ming Peng
Jei-Ming Peng
HCHan-Sun Chiang
Han-Sun Chiang
HCHou-Tsung Chen
Hou-Tsung Chen
Jai-Hong ChengJai-Hong Cheng
Jai-Hong Cheng
Background: Spinal cord injury (SCI) is a debilitating condition that results in severe motor function impairments. Current therapeutic options remain limited, underscoring the need for novel treatments. Extracorporeal shockwave therapy (ESWT) has emerged as a promising noninvasive approach for treating musculoskeletal disorders and nerve regeneration. Methods: This study explored the effects of low-energy ESWT on locomotor function, tissue regeneration, inflammation, and mitochondrial function in a rat SCI model. Experiments were performed using locomotor function assays, CatWalk gait analysis, histopathological examination, immunohistochemical, and immunofluorescence staining. Results: The findings demonstrated that low-energy ESWT had a dose-dependent effect, with three treatment sessions (ESWT3) showing superior outcomes compared to a single session. ESWT3 significantly improved motor functions [run patterns, run average speed, and maximum variation, as well as the Basso, Beattie, and Bresnahan score] and promoted tissue regeneration while reducing inflammation. ESWT3 significantly decreased levels of IL-1β, IL6, and macrophages (CD68) while increasing leukocyte (CD45) infiltration. Additionally, ESWT3 upregulated NueN and mitofusin 2 (MFN2), suggesting enhanced neuronal health and mitochondrial function. Moreover, ESWT3 modulated the expression of fibroblast growth factor 1 (FGF1), FGF2, their receptor FGFR1 and phosphorylation of ERK, aiding tissue repair, and regeneration in SCI. Conclusions: This study highlights the potential of low-energy ESWT as an effective noninvasive treatment for SCI, demonstrating significant improvements in motor recovery, tissue regeneration, anti-inflammatory effects, and mitochondrial protection. These findings provide valuable insights into the mechanisms of ESWT and its therapeutic application for SCI recovery.

6 March 2025 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
CCCheh-Yung Chang
Cheh-Yung Chang
HCHou-Tsung Chen
Hou-Tsung Chen
FYFu-Shine Yang
Fu-Shine Yang
HCHsu Chieh-Cheng
Hsu Chieh-Cheng
TYTsung-Cheng Yin
Tsung-Cheng Yin
MLMeng-Ling Lu
Meng-Ling Lu

19 February 2025 in Clinical Spine Surgery
Verified
Journal Article
Open access
HCHou-Tsung Chen
Hou-Tsung Chen
RWRe-Wen Wu
Re-Wen Wu
FYFu-Shine Yang
Fu-Shine Yang
CCCheh-Yung Chang
Cheh-Yung Chang
HCHsu Chieh-Cheng
Hsu Chieh-Cheng
MLMeng-Ling Lu
Meng-Ling Lu
Study Design: This is a retrospective cohort study. Objective: To evaluate the combined modified percutaneous short-segment posterior instrumentation technique by reducing and fixating the thoracolumbar burst fracture and checking the efficacy of indirect spinal decompression using intraoperative CT. This study aims to (1) demonstrate that using modified percutaneous short-segment posterior instrumentation is enough to rebuild spinal stability and decompress the spinal stenosis for thoracolumbar burst fracture and (2) prove the effects of spinal canal decompression by intraoperative portable CT with the surgical technique. Summary of Background Data: Various posterior instrumentation methods have been used to treat thoracolumbar burst fractures and decompress retropulsed bony fragments through ligamentotaxis, but no studies have assessed the efficacy of combining percutaneous short-segment posterior instrumentation with intraoperative CT. Methods: Using modified percutaneous short-segment posterior instrumentation to rebuild the spinal stability and ligamentotaxis effect to indirect decompression of the spinal stenosis without laminectomy and check parameters immediately after surgery by real-time intraoperative portable CT. Results: Fifty-seven patients with thoracolumbar burst fractures underwent modified percutaneous short-segment posterior instrumentation from 2018 to 2023 at a single medical center. Mean injured vertebral canal dimension increased from 90.8±26.3 to 122.1±30.3 mm 2 ( P <0.05) and mean canal encroachment index decreased from 44.8±9.5% to 25.6±4.8% ( P <0.05), the anterior body height increased from 13.9±3.8 to 25.9±3.9 mm ( P <0.01) and kyphotic angle decreased from 27.3±3.2 to 8.6±2.1 degrees ( P <0.01). Neurological function was improved by at least 1 Frankel grade in neurological deficit patients. No significant difference in kyphotic angle between post-op and 6-month follow-up. Conclusions: Indirect decompression of the spinal canal with modified percutaneous short-segment fixation without laminectomy was an effective treatment for thoracolumbar burst fracture, even in selected incomplete neurological deficits patients.

12 December 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Jai-Hong ChengJai-Hong Cheng
Jai-Hong Cheng
JCJeng Wei Chen
Jeng Wei Chen
WCWen-Yi Chou
Wen-Yi Chou
PCPo-Cheng Chen
Po-Cheng Chen
KWKuan-Ting Wu
Kuan-Ting Wu
HCHou-Tsung Chen
Hou-Tsung Chen
Background: Osteoporosis (OP) is a chronic inflammatory bone disease characterized by reduced bone structure and strength, leading to increased fracture risk. Effective therapies targeting both bone and cartilage are limited. This study compared the therapeutic effects of extracorporeal shockwave therapy (ESWT), bisphosphonate (Aclasta), and human Wharton jelly-derived mesenchymal stem cells (WJMSCs) in a rat model of OP. Methods: Female rats were assigned to four groups: Sham (no surgery or treatment), OP (bilateral ovariectomy, OVX), ESWT (OVX + ESWT on both tibias at 0.25 mJ/mm2, 1500 impulses per tibia), Aclasta (OVX + zoledronic acid 0.1 mg/kg via tail vein injection), and WJMSC (OVX + 2 × 10⁶ WJMSCs). Pathological changes, bone microarchitecture (by micro-CT), serum cytokines (by ELISA), and tissue-specific molecular markers (by immunohistochemistry) were evaluated. Results: All treatments improved bone density, preserved cartilage, and modulated cytokines (IL31, IL33, VEGF, and BMP2), with Aclasta showing the greatest improvements in bone parameters and cartilage preservation. ESWT and WJMSC also demonstrated significant effects, with ESWT highlighting non-invasive chondroprotective potential. Conclusions: Aclasta provided the best overall therapeutic response, particularly in bone regeneration. However, ESWT and WJMSC also showed comparable chondroprotective effects. ESWT emerges as a promising non-invasive alternative for OP management when pharmacological or cell-based therapies are not feasible.

23 October 2026 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
HCHsuan Chiu
Hsuan Chiu
KWKuan-Ting Wu
Kuan-Ting Wu
FKFeng-Chih Kuo
Feng-Chih Kuo
HCHou-Tsung Chen
Hou-Tsung Chen
AHAllen Herng Shouh Hsu
Allen Herng Shouh Hsu
Background: Anemia in intertrochanteric fractures (ITFs) is associated with higher morbidity and mortality and is an independent risk factor of functional mobility. Numerous studies have examined blood loss after different fixation systems. However, there is limited literature assessing the correlation of different variables that could influence blood loss in ITFs. The purpose of this study is to assess blood loss in ITFs stabilized using either dynamic hip screw (DHS) or cephalomedullary nail (CMN). Materials and methods: Perioperative blood loss was evaluated in 621 consecutive patients treated for ITFs with DHS and CMN between March 2011 and January 2021. Estimated blood loss (EBL) was calculated using the modified Lisander formula. Multivariable linear regression was performed to assess associations between implant type and EBL, adjusting for age, sex, BMI, ASA score, fracture pattern (AO/OTA type 31A1 and 31A2), anticoagulant use, and time to surgery (early: <48 h vs. late: ≥48 h). Results: DHS was associated with significantly lower EBL (613.7 mL vs. 728.7 mL; p < 0.001). In multivariable analysis, CMN was independently associated with higher blood loss (β = 119.4 mL; 95% CI 42.2–196.7; p = 0.003). Use of anticoagulants, male sex, and higher fracture severity (A2 vs. A1) were also associated with increased blood loss. DHS showed a trend toward lower transfusion volume (CMN vs. DHS, β = 65.3 mL; 95% CI -46.8–102.0; p = 0.138), though implant type was not a significant predictor of transfusion requirement (CMN vs. DHS, OR = 1.040; p = 0.212). Surprisingly, anticoagulant use was associated with slightly lower EBL (β= -109.5 mL; 95% CI -186.7– -32.3; p = 0.006). Conclusions: DHS was associated with lower perioperative blood loss and reduced transfused volume compared to CMN in AO/OTA type 31A1 and 31A2 ITFs. These findings support DHS as a potential option for patients at higher risk of anemia or transfusion-related complications.